RAF1 and neoplasm: While the reasons for the lack of in vitro response to the RAF/MEKi is not completely understood, it is worth noting that UTE2 was the only EAC showing a moderate degree of differentiation (i.e., G2) and the only primary tumor cell line established from a patient harboring early stage (i.e., IB) disease.